De-implementation of Axillary Dissection in Women Undergoing Mastectomy for Breast Cancer-Reference-Cited by-同舟云学术

De-implementation of Axillary Dissection in Women Undergoing Mastectomy for Breast Cancer

Published:2023-06-16 Issue:9 Volume:30 Page:5692-5702
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Leonard Laura D.,de Araujo Thiago B.,Quinn Christopher,Thomas Madeline B.^ORCID,Beaty Laurel,Mott Nicole M.,Colborn Kathryn,Heelan Alicia A.,Tevis Sarah E. A.,Christian Nicole,Arhendt Gretchen,Gleisner Ana L.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-023-13698-8.pdf

Reference26 articles.

1. Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318(10):918–26.

2. Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial. Lancet Oncol. 2013;14(4):297–305.

3. Solá M, Alberro JA, Fraile M, Santesteban P, Ramos M, Fabregas R, et al. Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048/13/2000. Ann Surg Oncol. 2013;20(1):120–7.

4. Yan M, Abdi MA, Falkson C. Axillary management in breast cancer patients: a comprehensive review of the key trials. Clin Breast Cancer. 2018;18(6):e1251–9.

5. Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, Mansel RE, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981–22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15(12):1303–10.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementation of Choosing Wisely® Recommendations for Lymph Node Surgery in Male Breast Cancer;Annals of Surgical Oncology;2024-07-20